Parallel approaches to the discovery of novel BRD4 inhibitors

被引：0
|
作者：
Jones, David H. [1 ]
de Groot, Marcel J. [1 ]
Heald, Robert [1 ]
Arhin, Ebenezer [1 ]
Goodwin, Ria [1 ]
Burton, Brenda [1 ]
Kulagowski, Jan [1 ]
Brown, David [1 ]
Irving, Steven [1 ]
Bazin, Richard [1 ]
Bruce, Deborah [1 ]
Devos, Rene [1 ]
Price, Steven [1 ]
Ray, Nick [1 ]
Lockey, Peter [1 ]
Montana, John [1 ]
Albertella, Mark R. [1 ]
Green, Simon R. [1 ]
机构：
[1] Argenta, Harlow, Essex, England
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-5137
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5137
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Drug Discovery of Acetophenone Derivatives as BRD4 Inhibitors
    Zhang, Zhimin
    Huang, Wenhai
    Zheng, Xiaoliang
    Li, Chuansheng
    Shen, Zhengrong
    LETTERS IN DRUG DESIGN & DISCOVERY, 2020, 17 (03) : 323 - 329
  • [2] Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis
    Zhangxu He
    Haomiao Jiao
    Qi An
    Xin Zhang
    Dan Zengyangzong
    Jiale Xu
    Hongmin Liu
    Liying Ma
    Wen Zhao
    Acta Pharmaceutica Sinica B, 2022, 12 (01) : 291 - 307
  • [3] Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis
    He, Zhangxu
    Jiao, Haomiao
    An, Qi
    Zhang, Xin
    Zengyangzong, Dan
    Xu, Jiale
    Liu, Hongmin
    Ma, Liying
    Zhao, Wen
    ACTA PHARMACEUTICA SINICA B, 2022, 12 (01) : 291 - 307
  • [4] Discovery, optimization and biological evaluation of chromone derivatives as novel BRD4 inhibitors
    Jia, Zhao-Tong
    Li, You
    Shi, Wei
    Qian, Jian-Qiang
    Xu, Ya-Yu
    Fan, Hai-Ran
    Hu, Xiao-Long
    Wang, Hao
    MEDICINAL CHEMISTRY RESEARCH, 2025, 34 (03) : 720 - 744
  • [5] Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer
    Zhang, Sitao
    Chen, Yanzhao
    Tian, Chengsen
    He, Yujing
    Tian, Zeru
    Wan, Yichao
    Liu, Tingting
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (09) : 1775 - 1795
  • [6] Discovery of Potent and Novel Dual PARP/BRD4 Inhibitors for Efficient Treatment of Pancreatic Cancer
    Wang, Shu-Ping
    Li, Yu
    Huang, Shi-Hui
    Wu, Shi-Qi
    Gao, Ling-Li
    Sun, Qin
    Lin, Qian-Wen
    Huang, Lei
    Meng, Liu-Qiong
    Zou, Yi
    Zhu, Qi-Hua
    Xu, Yun-Gen
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (23) : 17413 - 17435
  • [7] Discovery of potent and novel dual NAMPT/BRD4 inhibitors for efficient treatment of hepatocellular carcinoma
    Yin, Chunjia
    Jia, Shuting
    Yang, Xiaojuan
    Wu, Liqiang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 271
  • [8] Discovery of selective HDAC/BRD4 dual inhibitors as epigenetic probes
    Chen, Jingjing
    Li, Yalei
    Zhang, Jie
    Zhang, Minmin
    Wei, Aihuan
    Liu, Hongchun
    Xie, Zhicheng
    Ren, Wenming
    Duan, Wenwen
    Zhang, Zhuo
    Shen, Aijun
    Hu, Youhong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 209
  • [9] Discovery and lead identification of quinazoline-based BRD4 inhibitors
    Yang, Shyh-Ming
    Urban, Daniel J.
    Yoshioka, Makoto
    Strovel, Jeffrey W.
    Fletcher, Steven
    Wang, Amy Q.
    Xu, Xin
    Shah, Pranav
    Hu, Xin
    Hall, Matthew D.
    Jadhav, Ajit
    Maloney, David J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (21) : 3483 - 3488
  • [10] Synthesis and evaluation of novel dual BRD4/HDAC inhibitors
    Amemiya, Seika
    Yamaguchi, Takao
    Hashimoto, Yuichi
    Noguchi-Yachide, Tomomi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (14) : 3677 - 3684
12345